Literature DB >> 28161395

Somatic clonal evolution: A selection-centric perspective.

Jacob Scott1, Andriy Marusyk2.   

Abstract

It is generally accepted that the initiation and progression of cancers is the result of somatic clonal evolution. Despite many peculiarities, evolution within populations of somatic cells should obey the same Darwinian principles as evolution within natural populations, i.e. variability of heritable phenotypes provides the substrate for context-specific selection forces leading to increased population frequencies of phenotypes, which are better adapted to their environment. Yet, within cancer biology, the more prevalent way to view evolution is as being entirely driven by the accumulation of "driver" mutations. Context-specific selection forces are either ignored, or viewed as constraints from which tumor cells liberate themselves during the course of malignant progression. In this review, we will argue that explicitly focusing on selection forces acting on the populations of neoplastic cells as the driving force of somatic clonal evolution might provide for a more accurate conceptual framework compared to the mutation-centric driver gene paradigm. Whereas little can be done to counteract the "bad luck" of stochastic occurrences of cancer-related mutations, changes in selective pressures and the phenotypic adaptations they induce can, in principle, be exploited to limit the incidence of cancers and to increase the efficiency of existing and future therapies. This article is part of a Special Issue entitled: Evolutionary principles - heterogeneity in cancer?, edited by Dr. Robert A. Gatenby.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Driver; Initiation; Natural selection; Progression; Selective pressures

Mesh:

Substances:

Year:  2017        PMID: 28161395     DOI: 10.1016/j.bbcan.2017.01.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta Rev Cancer        ISSN: 0304-419X            Impact factor:   10.680


  24 in total

Review 1.  Genes and genomes and unnecessary complexity in precision medicine.

Authors:  Rama S Singh; Bhagwati P Gupta
Journal:  NPJ Genom Med       Date:  2020-05-04       Impact factor: 8.617

Review 2.  Informatics for cancer immunotherapy.

Authors:  J Hammerbacher; A Snyder
Journal:  Ann Oncol       Date:  2017-12-01       Impact factor: 32.976

Review 3.  Reviewing cancer's biology: an eclectic approach.

Authors:  Ibrahim Diori Karidio; Senay Hamarat Sanlier
Journal:  J Egypt Natl Canc Inst       Date:  2021-11-01

Review 4.  Harnessing Tumor Evolution to Circumvent Resistance.

Authors:  Katherine L Pogrebniak; Christina Curtis
Journal:  Trends Genet       Date:  2018-06-11       Impact factor: 11.639

Review 5.  The Genetic/Non-genetic Duality of Drug 'Resistance' in Cancer.

Authors:  Ravi Salgia; Prakash Kulkarni
Journal:  Trends Cancer       Date:  2018-02-03

6.  DDIT4 Novel Mutations in Pancreatic Cancer.

Authors:  Fadian Ding; Xiaoping Hong; Xiangqun Fan; Shirong Huang; Wei Lian; Xingting Chen; Qicai Liu; Youting Chen; Feng Gao
Journal:  Gastroenterol Res Pract       Date:  2021-04-30       Impact factor: 2.260

7.  Single-cell analysis reveals selection of TP53-mutated clones after MDM2 inhibition.

Authors:  Nabih Maslah; Emmanuelle Verger; Stéphane Giraudier; Mathias Chea; Ronald Hoffman; John Mascarenhas; Bruno Cassinat; Jean-Jacques Kiladjian
Journal:  Blood Adv       Date:  2022-05-10

8.  Optimizing adaptive cancer therapy: dynamic programming and evolutionary game theory.

Authors:  Mark Gluzman; Jacob G Scott; Alexander Vladimirsky
Journal:  Proc Biol Sci       Date:  2020-04-22       Impact factor: 5.530

Review 9.  Cancer and intercellular cooperation.

Authors:  Marta Bertolaso; Anna Maria Dieli
Journal:  R Soc Open Sci       Date:  2017-10-04       Impact factor: 2.963

10.  Evolutionary dynamics of incubation periods.

Authors:  Bertrand Ottino-Loffler; Jacob G Scott; Steven H Strogatz
Journal:  Elife       Date:  2017-12-21       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.